Literature DB >> 29279554

Topics on the molecular pathogenesis and therapeutic approaches for T/NK-cell lymphoma.

Motoko Yamaguchi1.   

Abstract

Entities:  

Keywords:  NK/T-cell lymphoma; T-cell lymphoma

Mesh：

Substances：

Year:  2017        PMID： 29279554      PMCID： PMC6144184          DOI： 10.3960/jslrt.57001

Source DB:  PubMed          Journal:  J Clin Exp Hematop        ISSN： 1346-4280


× No keyword cloud information.
  8 in total

Review 1.  Recent Progress in the Understanding of Angioimmunoblastic T-cell Lymphoma.

Authors:  Manabu Fujisawa; Shigeru Chiba; Mamiko Sakata-Yanagimoto
Journal:  J Clin Exp Hematop       Date:  2017

Review 2.  Anaplastic large cell lymphoma: pathology, genetics, and clinical aspects.

Authors:  Naoko Tsuyama; Kana Sakamoto; Seiji Sakata; Akito Dobashi; Kengo Takeuchi
Journal:  J Clin Exp Hematop       Date:  2017

Review 3.  Treatment advances and prognosis for patients with adult T-cell leukemia-lymphoma.

Authors:  Hiroo Katsuya; Kenji Ishitsuka
Journal:  J Clin Exp Hematop       Date:  2017-06-08

4.  Treatments and Outcomes of Patients With Extranodal Natural Killer/T-Cell Lymphoma Diagnosed Between 2000 and 2013: A Cooperative Study in Japan.

Authors:  Motoko Yamaguchi; Ritsuro Suzuki; Masahiko Oguchi; Naoko Asano; Jun Amaki; Takeshi Akiba; Takeshi Maeda; Satoshi Itasaka; Nobuko Kubota; Yoshihiro Saito; Yukio Kobayashi; Jun Itami; Kyoko Ueda; Kana Miyazaki; Noriko Ii; Naoto Tomita; Nodoka Sekiguchi; Jun Takizawa; Bungo Saito; Tohru Murayama; Toshihiko Ando; Hideho Wada; Rie Hyo; Yasuo Ejima; Masatoshi Hasegawa; Naoyuki Katayama
Journal:  J Clin Oncol       Date:  2016-10-31       Impact factor: 44.544

5.  Prognostic index for chronic- and smoldering-type adult T-cell leukemia-lymphoma.

Authors:  Hiroo Katsuya; Mototsugu Shimokawa; Kenji Ishitsuka; Kazuhiro Kawai; Masahiro Amano; Atae Utsunomiya; Ryosuke Hino; Shuichi Hanada; Tatsuro Jo; Kunihiro Tsukasaki; Yukiyoshi Moriuchi; Eisaburo Sueoka; Shinichiro Yoshida; Hitoshi Suzushima; Masaharu Miyahara; Kiyoshi Yamashita; Tetsuya Eto; Junji Suzumiya; Kazuo Tamura
Journal:  Blood       Date:  2017-05-17       Impact factor: 22.113

Review 6.  Current treatment approaches for NK/T-cell lymphoma.

Authors:  Motoko Yamaguchi; Kana Miyazaki
Journal:  J Clin Exp Hematop       Date:  2017-07-06

7.  RET, ROS1 and ALK fusions in lung cancer.

Authors:  Kengo Takeuchi; Manabu Soda; Yuki Togashi; Ritsuro Suzuki; Seiji Sakata; Satoko Hatano; Reimi Asaka; Wakako Hamanaka; Hironori Ninomiya; Hirofumi Uehara; Young Lim Choi; Yukitoshi Satoh; Sakae Okumura; Ken Nakagawa; Hiroyuki Mano; Yuichi Ishikawa
Journal:  Nat Med       Date:  2012-02-12       Impact factor: 53.440

8.  Somatic RHOA mutation in angioimmunoblastic T cell lymphoma.

Authors:  Mamiko Sakata-Yanagimoto; Terukazu Enami; Kenichi Yoshida; Yuichi Shiraishi; Ryohei Ishii; Yasuyuki Miyake; Hideharu Muto; Naoko Tsuyama; Aiko Sato-Otsubo; Yusuke Okuno; Seiji Sakata; Yuhei Kamada; Rie Nakamoto-Matsubara; Nguyen Bich Tran; Koji Izutsu; Yusuke Sato; Yasunori Ohta; Junichi Furuta; Seiichi Shimizu; Takuya Komeno; Yuji Sato; Takayoshi Ito; Masayuki Noguchi; Emiko Noguchi; Masashi Sanada; Kenichi Chiba; Hiroko Tanaka; Kazumi Suzukawa; Toru Nanmoku; Yuichi Hasegawa; Osamu Nureki; Satoru Miyano; Naoya Nakamura; Kengo Takeuchi; Seishi Ogawa; Shigeru Chiba
Journal:  Nat Genet       Date:  2014-01-12       Impact factor: 41.307
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.